• Monthly
  • $25
  • $50
  • $100
  • $other
  • use PayPal


Is it time for our Spring fundraiser already? If you enjoy what we offer, and have the means, please consider donating. The sooner we reach our modest goal, the faster we can get back to business as (un)usual. Please, stay safe and we’ll see you down the road.

The Logic of Medical Co-Payments

Aaron Carroll had a very useful NYT Upshot piece highlighting research showing that even modest co-payments discourage people from getting necessary medical care. The article is about co-payments for prescription drugs where it highlights research showing that people will often skip taking prescribed drugs to avoid co-payments. There are a couple of points worth making about co-payments in this context and more generally.

First, if a drug has been prescribed for a patient, then it is the judgement of a medical professional that they need this drug for their health. The argument for co-pays, that we want people to think twice before getting the treatment, really should not apply here since a medical professional has determined that they do need the treatment. It doesn’t make sense in general to encourage people to substitute their own judgement for that of a medical professional. (That doesn’t mean that medical professionals will always be right, but it would be best if patients made the determination to ignore their judgement based on their own research, not the desire to save a co-pay.)

The other point is that drugs are almost invariably cheap. By this I mean that they are cheap to manufacture and distribute. The research can be expensive, but this is a sunk cost at the point where the drug is being prescribed for the patient. If all drugs sold as generics, with no patent or related protections, they would rarely cost more than $10 or $20 per prescription. For this reason, there is not much savings to society if we get people to take fewer drugs, we are just risking people’s health with co-pays.

We do need to pay for the research. I suggest doing this upfront, with the government contracting out to private firms. All results and patents are in the public domain. (See Rigged, chapter 5 [it’s free].)

The issue with drugs is qualitatively different than with doctors’ visits. First, a visit to the doctor does require the use of a doctor’s time, as well as the time of their support staff and possibly other health care professionals. This means that there actually are savings from discouraging unnecessary visits.

The second point is that a decision to visit a doctor depends on the patient’s judgement, not that of a medical professional. (This is not the case with repeat treatments, just an initial visit.) People will always weigh a number of factors in deciding whether to visit a doctor, whether or not there is a co-pay.

For example, if they have a busy schedule or long-planned travel, they may choose not to see a doctor for a particular issue where they might otherwise see a doctor. In this context, it may be very reasonable to have a modest co-payment (e.g. $20 per visit — which would be waved for low income people) to make people think twice before seeing a doctor.

This sort of co-payment can be seen as analogous to charging people five cents for using a plastic bag when they shop, as many cities now do. If someone really wants the bag, the five cent fee will not prevent them from getting it, but it does get people to think twice, and therefore has led to a large decline in usage.

It is reasonable to think that a modest co-pay could have a similar effect on doctors visits. It should not prevent people with serious health issues from seeing a doctor, but it may discourage some visits for relatively trivial matters, like a cold.

Note, this is not the “skin in the game” story pushed by many economists, which wants patients to be comparative shoppers. There is considerable evidence that patients generally are not good at weighing the relative price of different treatments, and when they do, they often make the wrong choice for their health.

This is simply arguing that it would be good if patients think twice before rushing to see a doctor. We can’t guarantee that this will never mean that a person who needed to see a doctor chose not to, but in the alternative, we can’t guarantee that a person in desperate need to see a doctor won’t have to wait because the person in front of them in line has a cold.

This article first appeared on Dean Baker’s Beat the Press blog.

More articles by:

Dean Baker is the senior economist at the Center for Economic and Policy Research in Washington, DC. 

June 03, 2020
Anthony DiMaggio
Revolution, Not Riots: Prospects for Radical Transformation in the Covid-19 Era
Jennifer Loewenstein
From Mississippi to Minneapolis: Leaving the ‘Abyss of Despair’
Kenneth Surin
The UK Compared With Other Countries on the Pandemic
Paul Street
“Total Domination”: Popular Rebellion in the Shadow of Trumpism-Fascism
Kenn Orphan
The Sadism of American Power
John Pilger
The Coup Against ‘The Most Loyal Ally’
Eric Murphy
The Police Are The Out-Of-Towners Provoking Violence
Melvin Goodman
How the Washington Post Accommodates Disinformation
Rev. William Alberts
It’s the Worshippers Who Are “Essential”
Georgina Downs
No, the Public Fury Will Not “Move On” Prime Minister!
George V. Wright
It is Happening Here
M. G. Piety
Tales from the Dark Side of Customer Service, or “Christians” Giving Christians a Bad Name
Chandra Muzaffar
A Superpower in Chaos
Thomas Knapp
Time to Stop Messing Around and Strike at the Root of Police Violence
Thomas M. Hanna
The Oligopoly That Controls Our Digital Infrastructure Has Deepened Economic and Racial Divides
Andrew Stewart
The Ethics of Police Murder Video Exhibition: Democratizing The News Feed, Re-Traumatizing The Survivors, Or Both?
Binoy Kampmark
Death, Protest and George Floyd
David Rovics
Who’s Trashing Downtown Every Night and Why?
Harvey Wasserman
Trump Is No Accident
Behrooz Ghamari Tabrizi
Biden and the Common Sense Voter
Timothy Ingalsbee
Ecosystems, Logging and the Definition of Insanity
Elliot Sperber
The Birds of Brooklyn
June 02, 2020
Zoltan Grossman
Deploying Federal Troops in a War at Home Would Make a Bad Situation Worse
Nicholas Buccola
Amy Cooper is Christian Cooper’s Lost, Younger Sister 
Manuel García, Jr.
Global Warming is Nuclear War
Patrick Cockburn
An Unavoidable Recognition of Failure: Trump’s Withdrawal From Afghanistan
John Feffer
Is It Time to Boycott the USA?
Kathy Kelly
Beating Swords to Plowshares
Lawrence Davidson
U.S. Urban Riots Revisited
Sam Pizzigati
“Failed State” Status Here We Come
Ron Jacobs
In Defense of Antifa
Cesar Chelala
Bolsonaro and Trump: Separated at Birth
George Wuerthner
The BLM’s License to Destroy Sagebrush Ecosystems
Danny Antonelli
The Absurdity of Hope
Binoy Kampmark
Sinister Flatulence: Trump Versus Twitter
John Stanton
How Much Violence and Destruction is Enough for Depraved American Leaders and Their Subjects?
Richard C. Gross
The Enemy Within
Thomas Knapp
Trump’s “Free Speech:” Doctrine: Never, Ever, Ever Mention He’s a Liar
John W. Whitehead
This Is Not a Revolution. It’s a Blueprint for Locking Down the Nation
June 01, 2020
Joshua Frank
It’s a Class War Now Too
Richard D. Wolff
Why the Neoliberal Agenda is a Failure at Fighting Coronavirus
Henry Giroux
Racial Domestic Terrorism and the Legacy of State Violence
Ron Jacobs
The Second Longest War in the United States
Kanishka Chowdhury
The Return of the “Outside Agitator”
Lee Hall
“You Loot; We Shoot”